Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

2.92GBp
31 Jul 2014
Price Change (% chg)

0.00p (+0.00%)
Prev Close
2.92p
Open
2.92p
Day's High
--
Day's Low
--
Volume
113,682
Avg. Vol
1,694,878
52-wk High
3.80p
52-wk Low
1.38p

OXB.L

Chart for OXB.L

About

Oxford BioMedica plc (Oxford BioMedica) is a biopharmaceutical company developing gene-based medicines and therapeutic vaccines. The Company is evaluating product candidates for four ocular indications, including uveitis and three undisclosed genetic retinal diseases. The Company's technology platform includes a LentiVector gene... (more)

Overall

Beta: -0.13
Market Cap (Mil.): £72.97
Shares Outstanding (Mil.): 2,494.58
Dividend: --
Yield (%): --

Financials

  OXB.L Industry Sector
P/E (TTM): -- 107.05 36.29
EPS (TTM): -0.01 -- --
ROI: -75.02 -0.60 18.13
ROE: -77.75 -1.65 18.95
Search Stocks

BRIEF-Oxford Biomedica and Sanofi amend Ocular licence terms

Feb 17 - Oxford BioMedica PLC : * And sanofi amend terms for ocular licence * Sanofi granted global rights across all ocular disease indications for

17 Feb 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks